Gabriel A. Monteiro

Associate Professor



Research Activities

My research is focused on the manufacturing of plasmid and minicircles biopharmaceuticals.These vectors are being designed to be more efficiently expressed after administration in vivo. Simultaneously, modifications of the E. coli host strains are being carried out in order to increase the amount of the modified plasmids and minicircles. These projects are applied to the development of DNA vaccine prototypes against Avian Flu and African trypanosomiasis.



Selected Publications

Gonçalves, G. A. L., Prazeres, D. M. F., Monteiro, G.A., Prather, K. L. J. (2012) De novo creation of MG1655-derived E. coli strains specifically designed for plasmid DNA production, Appl. Microbiol. Biotechnol. 97, 611-620, doi:10.1007/s00253-012-4308-5

Toledo, M.A.S., Janissen, R., Favaro, M.T.P., Cotta, M.A., Monteiro, G.A., Prazeres, D.M.F., Souza, A.P., Azzoni, A.R. (2012) Development of a recombinant fusion protein based on the dynein light chain LC8 for non-viral gene delivery, J Control. Release 159, 222-231, doi:10.1016/j.jconrel.2012.01.011

Carvalho, J., Azzoni, A.R., Prazeres, D.M.F., Monteiro, G.A. (2010) Comparative analysis of antigen targeting sequences used in DNA vaccines, Mol. Biotechnol. 44, 204-212, doi:10.1007/s12033-009-9229-x

Oliveira, P.H., Prazeres D.M.F., Monteiro, G.A. (2009) Deletion formation mutations in plasmid expression vectors are unfavored by runaway amplification conditions and differentially selected under kanamycin stress, J. Biotechnol. 143, 231-238, doi:10.1016/j.jbiotec.2009.08.002

Silva, M.S., Prazeres, D.M.F., Lança, A., Atouguia, J., Monteiro, G.A. (2009) Trans-sialidase from Trypanosoma brucei as a potential target for DNA vaccine development against African trypanosomiasis, Parasitol. Res. 105, 1223-1229, doi:10.1007/s00436-009-1542-6"

E-mail (click on)